Stockreport

Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor [Seeking Alpha]

Bausch Health Companies Inc.  (BHC) 
Last bausch health companies inc. earnings: 2/19 06:59 am Check Earnings Report
PDF BHC's financials remain precarious, with Q3 2025 operating cash flow of $405M nearly offset by $397M in interest expense. Larsucosterol, BHC's next pipeline hope, is [Read more]